Detalhe da pesquisa
1.
Pharmacogenetic Aspects of COVID-19 Management and Post-COVID-19 Depression Treatment with Fluvoxamine.
Psychiatr Danub
; 34(Suppl 8): 25-30, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170697